Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
89bio, Inc. (ETNB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 577 shares @ $15.64, valued at $9k
Paid exercise price by delivering 1,014 shares @ $15.46, valued at $15.7k
08/21/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 4,501 shares @ $15.46, valued at $69.6k
08/21/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 346 shares @ $15.64, valued at $5.4k
Paid exercise price by delivering 753 shares @ $15.46, valued at $11.6k
08/21/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 577 shares @ $15.64, valued at $9k
Paid exercise price by delivering 1,014 shares @ $15.46, valued at $15.7k
08/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/11/2023 SC 13D/A RA CAPITAL MANAGEMENT, L.P. reports a 16.7% stake in 89BIO, INC.
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
07/18/2023 4 LAPORTE KATHLEEN (Director) has filed a Form 4 on 89bio, Inc.
Txns: Sold 12,500 shares @ $18.8, valued at $235k
Exercised 12,500 options to buy @ $2.64, valued at $33k
07/17/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,334 shares @ $0
Paid exercise price by delivering 2,882 shares @ $18.95, valued at $54.6k
07/05/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,334 shares @ $0
Paid exercise price by delivering 2,882 shares @ $18.95, valued at $54.6k
07/05/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 33,334 shares @ $0
Paid exercise price by delivering 16,527 shares @ $18.95, valued at $313.2k
07/05/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 5,834 shares @ $0
Paid exercise price by delivering 2,018 shares @ $18.95, valued at $38.2k
06/09/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of 89bio, Inc",
"Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of 89bio, Inc"
06/07/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Sold 15,000 shares @ $20, valued at $300k
Exercised 15,000 options to buy @ $1.93, valued at $29k
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 4 Atkinson Edward Morrow III (Director) has filed a Form 4 on 89bio, Inc.
Txns: Sold 6,250 shares @ $17.91, valued at $111.9k
Exercised 6,250 options to buy @ $2.61, valued at $16.3k
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/11/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Sold 13,683 shares @ $18.11, valued at $247.8k
Exercised 60,945 options to buy @ $3.11, valued at $189.5k
Exercised 18,626 options to buy @ $3.11, valued at $57.9k
05/09/2023 144 Form 144 - Report of proposed sale of securities:
05/05/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"89bio Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/25/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
04/24/2023 ARS Form ARS - Annual Report to Security Holders:
04/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/06/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Sold 8,721 shares @ $14.95, valued at $130.4k
04/04/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 5,833 shares @ $0
Paid exercise price by delivering 2,018 shares @ $15.23, valued at $30.7k
Granted 7,500 shares @ $0
Paid exercise price by delivering 2,594 shares @ $15.23, valued at $39.5k
04/04/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 33,333 shares @ $0
Paid exercise price by delivering 15,443 shares @ $15.23, valued at $235.2k
04/04/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,333 shares @ $0
Paid exercise price by delivering 2,882 shares @ $15.23, valued at $43.9k
04/04/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,333 shares @ $0
Paid exercise price by delivering 2,882 shares @ $15.23, valued at $43.9k
Granted 3,750 shares @ $0
Paid exercise price by delivering 1,297 shares @ $15.23, valued at $19.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy